187 related articles for article (PubMed ID: 24032636)
1. Influence of a modified propofol equilibration rate constant (k(e0)) on the effect-site concentration at loss and recovery of consciousness with the Marsh model.
Seo JH; Goo EK; Song IA; Park SH; Park HP; Jeon YT; Hwang JW
Anaesthesia; 2013 Dec; 68(12):1232-8. PubMed ID: 24032636
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of two Ke0 in the same pharmacokinetic propofol model: study on loss and recovery of consciousness.
Simoni RF; Esteves LO; Miziara LE; Cangiani LM; Alves GG; Romano AL; Hansen PÚ; Vianna PT
Rev Bras Anestesiol; 2011; 61(4):397-408. PubMed ID: 21724003
[TBL] [Abstract][Full Text] [Related]
3. The influence of target concentration, equilibration rate constant (ke0 ) and pharmacokinetic model on the initial propofol dose delivered in effect-site target-controlled infusion.
Glen JB; Engbers FH
Anaesthesia; 2016 Mar; 71(3):306-14. PubMed ID: 26682512
[TBL] [Abstract][Full Text] [Related]
4. Estimating the plasma effect-site equilibrium rate constant (Ke₀) of propofol by fitting time of loss and recovery of consciousness.
Wu Q; Sun B; Wang S; Zhao L; Qi F
Biol Pharm Bull; 2013; 36(9):1420-7. PubMed ID: 23803230
[TBL] [Abstract][Full Text] [Related]
5. Induction of general anaesthesia by effect-site target-controlled infusion of propofol: influence of pharmacokinetic model and ke0 value.
Thomson AJ; Morrison G; Thomson E; Beattie C; Nimmo AF; Glen JB
Anaesthesia; 2014 May; 69(5):429-35. PubMed ID: 24738800
[TBL] [Abstract][Full Text] [Related]
6. Influence of administration rate on propofol plasma-effect site equilibration.
Struys MM; Coppens MJ; De Neve N; Mortier EP; Doufas AG; Van Bocxlaer JF; Shafer SL
Anesthesiology; 2007 Sep; 107(3):386-96. PubMed ID: 17721240
[TBL] [Abstract][Full Text] [Related]
7. A novel technique to determine an 'apparent ke0 ' value for use with the Marsh pharmacokinetic model for propofol.
Thomson AJ; Nimmo AF; Engbers FH; Glen JB
Anaesthesia; 2014 May; 69(5):420-8. PubMed ID: 24738799
[TBL] [Abstract][Full Text] [Related]
8. [Reevaluation of the time course of the effect of propofol described with the Schnider pharmacokinetic model].
Sepúlveda PO; Mora X
Rev Esp Anestesiol Reanim; 2012 Dec; 59(10):542-8. PubMed ID: 23040653
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the performance of the Marsh model in effect site mode for target controlled infusion of propofol during the maintenance phase of general anaesthesia in an unselected population of neurosurgical patients.
Cowley NJ; Hutton P; Clutton-Brock TH
Eur J Anaesthesiol; 2013 Oct; 30(10):627-32. PubMed ID: 23962821
[TBL] [Abstract][Full Text] [Related]
10. Predictive ability of propofol effect-site concentrations during fast and slow infusion rates.
Sepúlveda PO; Cortínez LI; Recart A; Muñoz HR
Acta Anaesthesiol Scand; 2010 Apr; 54(4):447-52. PubMed ID: 20003124
[TBL] [Abstract][Full Text] [Related]
11. A comparison of two techniques for induction of anaesthesia with target-controlled infusion of propofol.
Mu JJ; Jiang T; Deng LP; Choi SW; Irwin MG; Yuen VM
Anaesthesia; 2018 Dec; 73(12):1507-1514. PubMed ID: 29956318
[TBL] [Abstract][Full Text] [Related]
12. Comparison of plasma compartment versus two methods for effect compartment--controlled target-controlled infusion for propofol.
Struys MM; De Smet T; Depoorter B; Versichelen LF; Mortier EP; Dumortier FJ; Shafer SL; Rolly G
Anesthesiology; 2000 Feb; 92(2):399-406. PubMed ID: 10691226
[TBL] [Abstract][Full Text] [Related]
13. Individual effect-site concentrations of propofol at return of consciousness are related to the concentrations at loss of consciousness and age in neurosurgical patients.
Nunes CS; Ferreira DA; Antunes L; Lobo F; Santos IA; Amorim P
J Clin Anesth; 2009 Feb; 21(1):3-8. PubMed ID: 19232933
[TBL] [Abstract][Full Text] [Related]
14. Gender differences between predicted and measured propofol C(P50) for loss of consciousness.
Kodaka M; Suzuki T; Maeyama A; Koyama K; Miyao H
J Clin Anesth; 2006 Nov; 18(7):486-9. PubMed ID: 17126774
[TBL] [Abstract][Full Text] [Related]
15. Study of the time course of the clinical effect of propofol compared with the time course of the predicted effect-site concentration: Performance of three pharmacokinetic-dynamic models.
Coppens M; Van Limmen JG; Schnider T; Wyler B; Bonte S; Dewaele F; Struys MM; Vereecke HE
Br J Anaesth; 2010 Apr; 104(4):452-8. PubMed ID: 20190259
[TBL] [Abstract][Full Text] [Related]
16. Performance of propofol target-controlled infusion models in the obese: pharmacokinetic and pharmacodynamic analysis.
Cortínez LI; De la Fuente N; Eleveld DJ; Oliveros A; Crovari F; Sepulveda P; Ibacache M; Solari S
Anesth Analg; 2014 Aug; 119(2):302-310. PubMed ID: 24977639
[TBL] [Abstract][Full Text] [Related]
17. Estimation of the plasma effect site equilibration rate constant (ke0) of propofol in children using the time to peak effect: comparison with adults.
Muñoz HR; Cortínez LI; Ibacache ME; Altermatt FR
Anesthesiology; 2004 Dec; 101(6):1269-74. PubMed ID: 15564932
[TBL] [Abstract][Full Text] [Related]
18. A step towards effect-site target-controlled infusion with propofol in dogs: a k(e0) for propofol.
Brás S; Bressan N; Ribeiro L; Ferreira DA; Antunes L; Nunes CS
J Vet Pharmacol Ther; 2009 Apr; 32(2):182-8. PubMed ID: 19290949
[TBL] [Abstract][Full Text] [Related]
19. Targeting effect compartment or central compartment concentration of propofol: what predicts loss of consciousness?
Wakeling HG; Zimmerman JB; Howell S; Glass PS
Anesthesiology; 1999 Jan; 90(1):92-7. PubMed ID: 9915317
[TBL] [Abstract][Full Text] [Related]
20. [Comparative study between fast and slow induction of propofol given by target-controlled infusion: expected propofol concentration at the effect site. Randomized controlled trial].
Simoni RF; Miziara LE; Esteves LO; Silva Dde O; Ribeiro CA; Smith MO; Paula LF; Cangiani LH
Rev Bras Anestesiol; 2015; 65(2):99-103. PubMed ID: 25740275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
